About: Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2001 (uk) im August 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2001 (ast) scientific article published on 01 August 2001 (en)
publication date	wds:Q74320805-34CE1444-D92E-4BB8-95A8-4F27B8D8F2F7
publication date	2001-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74320805-1EEDC023-BDCE-4F27-BE16-E0DF053E100F
language of work or name	English
cites work	wds:Q74320805-13FA7A1A-7709-4DBB-9B51-9FD041B8075B wds:Q74320805-259D30ED-3436-48D4-ABFE-F4D5619852CB wds:Q74320805-4130602E-AB5C-4541-B541-E43E10C3AC93 wds:Q74320805-576B0BE9-EC9D-40D3-8DC3-27DA93318596 wds:Q74320805-5A1E425B-4664-42D7-B07F-551E38EBC08D wds:Q74320805-5BE36462-9579-4A0D-B3B2-C27164C20143 wds:Q74320805-6418FD73-ABB2-41D8-9F94-28CF7C7264D2 wds:Q74320805-68122D72-C6DF-4DE4-90E0-295AF8F713EC wds:Q74320805-A2D387DD-C52C-4719-9A64-DD26BC2BE4D4 wds:Q74320805-B9F0B14F-A5DE-4979-83CA-250068327E64 wds:Q74320805-D0E038E1-9898-48B9-9903-350D197A6291 wds:Q74320805-D2D74F74-C8E8-49A9-A46E-2D60F5DEB0B0 wds:Q74320805-D44570A1-23D6-4A55-A790-BD73EDC2B876 wds:Q74320805-D618F692-9C90-44D2-B2B2-BD77893F67E4 wds:Q74320805-F9D327B5-23C1-4100-86DE-BB997DC52F5A wds:Q74320805-F9E4945A-1219-43D8-A12E-FB31E4743ECD
cites work	Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation Early androgen deprivation for prostate cancer? Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31 Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group The Value of Testosterone Deprivation in Stage D1 Carcinoma of the Prostate Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06 Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcome Surgically staged patients with prostatic carcinoma treated with definitive radiotherapy: fifteen-year results Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancer
author name string	wds:Q74320805-04EAF412-7889-4860-A5B4-9E84B0C934F8 wds:Q74320805-06047BF2-E0E9-484C-8FA0-3B821C357E95 wds:Q74320805-B33594AC-1B07-4A0F-AFA3-DF0A5F4C6EAB
author name string	A Pollack G K Zagars A C von Eschenbach
rdfs:label	Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer (en) Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer (nl)
skos:prefLabel	Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer (en) Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer (nl)
name	Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer (en) Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer (nl)
title	wds:Q74320805-A0A48E14-CFDD-44E7-9F20-BD9B40AA16FC
title	Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer (en)
page(s)	wds:Q74320805-83C3A86E-EDAF-4B38-8467-7BEB2F836D02
page(s)	233-239
instance of	wds:Q74320805-BA4D1544-2BAD-4E04-99D7-9AF651EAC31C
instance of	scholarly article
main subject	wds:Q74320805-5F21CF56-1B24-400C-885E-17F908C270E1
main subject	prostate cancer
PubMed ID	wds:Q74320805-17163534-0E98-4FF9-B50F-25465E099859
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11489709
PubMed ID	11489709
published in	wds:Q74320805-73B34B36-7D58-4FD1-9BB8-37D2149E5BDD
published in	Urology
issue	wds:Q74320805-D00E80D6-772D-409E-B3E5-2F7A51458FEB
volume	wds:Q74320805-BB350129-12D7-4969-B9F9-D3D6BCE07208
issue	2
volume	58
DOI	wds:Q74320805-90F56AA5-FF6A-47B8-83D1-50275E0E76EB
DOI	http://dx.doi.org/10.1016/S0090-4295(01)01168-2
DOI	10.1016/S0090-4295(01)01168-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74320805
is cites work of	The natural history of noncastrate metastatic prostate cancer after radical prostatectomy Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort Highlights of contemporary issues in the medical management of prostate cancer Current status of lymph node-positive prostate cancer: Incidence and predictors of outcome The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer. Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated? The Role of Local Therapy for Oligometastatic Prostate Cancer: Should We Expect a Cure? Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatment Radiotherapy before and after radical prostatectomy for high-risk and locally advanced prostate cancer Follow-up surveillance strategies for genitourinary malignancies Anoikis is regulated by BCL-2-independent pathways in human prostate carcinoma cells Favorable outcome of intraoperative radiotherapy to the primary site in patients with metastatic prostate cancer Treatment options in lymph node-positive prostate cancer Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review. Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies Molecular targets for radiation oncology in prostate cancer. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer Comparison of external radiation therapy vs radical prostatectomy in lymph node positive prostate cancer patients. The oncologic role of local treatment in primary metastatic prostate cancer Long-term outcome for lymph node-positive prostate cancer Timing of androgen deprivation for prostate cancer: benefits versus side effects--a patient-physician dialogue [Radiotherapy in node-positive prostate cancer].

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software